Evolocumab attenuates myocardial ischemia/reperfusion injury by blocking PCSK9/LIAS-mediated cuproptosis of cardiomyocytes
Zi-Zhuo Li, Lei Guo, Yuqiu An, Wei-Jia Yu, Dailun Shi, Qiu‐Yue Lin, Bo Zhang
Topics & Concepts
Blocking (statistics)PCSK9EvolocumabReperfusion injuryIschemiaMedicineMyocardial ischemiaCardiologyMyocardial Reperfusion InjuryInternal medicinePharmacologyCholesterolLDL receptorComputer scienceApolipoprotein BComputer networkApolipoprotein A1LipoproteinLipoproteins and Cardiovascular HealthMetal complexes synthesis and propertiesCancer, Lipids, and Metabolism